Clinical results with a new low dose oral contraceptive utilizing norethindrone/ethinyl estradiol
Pasquale, S.A.; Yuliano, E.
Contraception 12(5): 495-503
1975
ISSN/ISBN: 0010-7824 PMID: 1192736 DOI: 10.1016/0010-7824(75)90011-6Document Number: 506768
Document emailed within 0-6 h
Related Documents
Hanson, F.W.; Niswander, K.R. 1974: A new low dose norethindrone acetate (0.6 mg) ethinyl estradiol (30 mcg) combination oral contraceptive Journal of Reproductive Medicine 12(3): 109-111Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Akerlund, M. 1997: Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol Acta Obstetricia et Gynecologica Scandinavica. Suppl 164: 63-65
Garg, V.; van Heeswijk, R.; Yang, Y.; Kauffman, R.; Smith, F.; Adda, N. 2012: The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir Journal of Clinical Pharmacology 52(10): 1574-1583
Lin, W.H.; Feng, H.-P.; Shadle, C.R.; O'Reilly, T.; Wagner, J.A.; Butterton, J.R. 2014: Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone European Journal of Clinical Pharmacology 70(9): 1107-1113
Hofmann, B.; Reinecke, I.; Schuett, B.; Merz, M.; Zurth, C. 2014: Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive International Journal of Clinical Pharmacology and Therapeutics 52(12): 1059-1070
Boerrigter, P.J.; Ellman, H.; Dolker, M. 1999: International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg Clinical Therapeutics 21(1): 118-127
Kroll, R.; Ackerman, R.; Feldman, R.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2016: Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol Contraception 93(3): 249-256
Ruíz Moreno, J.A.; Rubio Lotvin, B.; Bolio Arista, R.; de Larios, N.M. 1977: A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive Ginecologia y Obstetricia de Mexico 41(244): 179-184
Portman, D.J.; Kaunitz, A.M.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2014: Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception 89(4): 299-306
Lobo Abascal, P.; Luzar-Stiffler, V.; Giljanovic, S.; Howard, B.; Weiss, H.; Trussell, J. 2016: Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(1): 88-91
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
Morigi, E.M.; Pasquale, S.A. 1978: Clinical experience with a low dose oral contraceptive containing norethisterone and ethinyl oestradiol Current Medical Research and Opinion 5(8): 655-662
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Skouby, S.O. 1987: Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study International Journal of Fertility 32 Suppl: 45-48
Kriplani, A.; Periyasamy, A.J.; Agarwal, N.; Kulshrestha, V.; Kumar, A.; Ammini, A.C. 2010: Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome Contraception 82(2): 139-146
Kaunitz, A.; Archer, D.; Foegh, M. 2012: Safety and tolerability of the agile patch, a contraceptive patch with low-dose ethinyl estradiol (EE) and levonorgestrel (LNG), vs. combination oral contraceptives (COCs) in obese vs. non-obese women Fertility and Sterility 98(3): S195-S196
Archer, D.F.; Maheux, R.; DelConte, A.; O'Brien, F.B. 1999: Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG) American Journal of Obstetrics and Gynecology 181(5 Pt 2): 39-44